New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

PPHvsGDOCETF Comparison

ETF 1
PPH

VanEck Pharmaceutical ETF

This fund is part of
Uncategorized Equities
-0.25%
VS
ETF 2
GDOC

Goldman Sachs Future Health Care Equity ETF

This fund is part of
Healthcare Technology
-0.63%

VanEck Pharmaceutical ETF (PPH) belongs to the Uncategorized Equities segment. Goldman Sachs Future Health Care Equity ETF (GDOC) is part of the Healthcare Technology segment. Both ETFs have the same top 1 sector exposures: Healthcare. PPH is less expensive with a Total Expense Ratio (TER) of 0.36%, versus 0.75% for GDOC. PPH is up 13.41% year-to-date (YTD) with -$316M in YTD flows. GDOC performs worse with 5.57% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of PPH and GDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PPH vs GDOC performance and flow charts

Performance

-2.00.02.04.06.0%Sep 23Sep 30Oct 7Oct 14Oct 21

Cumulative Flows

020,000,00040,000,00060,000,00080,000,000100,000,000Sep 23Sep 30Oct 7Oct 14Oct 21

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/23/2026
1M3MYTD1Y3Y5Y
Perf.
PPH
GDOC
+4.67%+1.76%
+4.95%+4.97%
+13.41%+5.57%
+26.91%+9.73%
+57.53%+30.59%
+69.99%n/a
Flows
PPH
GDOC
+$15M-
+$61M-
-$316M-$2M
-$397M-$2M
+$356M-$85M
+$450M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
PPH
GDOC
+19.86%+15.37%
+18.46%+15.53%
+16.43%+15.05%
+15.78%n/a
Max drawdown
PPH
GDOC
-8.47%-7.14%
-10.78%-15.39%
-17.98%-22.18%
-20.19%n/a
Max drawdown duration
PPH
GDOC
59d65d
122d221d
434d449d
484dn/a
Trading data

Create an account to view trading data

Join for free
PPH
GDOC
Last sale
10/23/2026 at 1:30 PM
$114.93
$37.62
Previous close
10/22/2026
$117.04
$37.95
Consolidated volume
10/22/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

GDOC
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
PPH
GDOC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/23/2026 at 1:30 PM
Live
Closed
PPH
GDOC
Last price
$114.93
$37.62
1D performance
-1.80%
-0.89%
AuM$1.06 B$19.75 M
E/R0.36%0.75%
Characteristics
PPH
GDOC
Management strategyPassiveActive
ProviderVanEckGoldman Sachs
BenchmarkMVIS US Listed Pharmaceutical 25 Index-
N° of holdings2537
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateDecember 20, 2011November 11, 2021
ESGNoNo
Advertisement
Exposure

Countries

PPH
USA
62.46%
United Kingdom
10.95%
Switzerland
10.06%
Other
16.53%
GDOC
USA
80.11%
Other
19.89%

Sectors

PPH
Healthcare
100%
Other
0%
GDOC
Healthcare
97.08%
Other
2.92%
Advertisement

Diversification

PPH

Total weight of top 15 holdings out of 15

90.56%
GDOC

Total weight of top 15 holdings out of 15

71.2%

Top 15 holdings

Data as of August 31, 2026
PPH
Eli Lilly & Co.
19.11%
Merck & Co., Inc.
10.96%
Novartis AG
10.06%
Pfizer Inc.
5.05%
Bristol Myers Squibb Co.
4.98%
Novo Nordisk A/S
4.92%
McKesson Corp.
4.70%
AbbVie, Inc.
4.48%
Johnson & Johnson
4.43%
GSK Plc
4.13%
Sanofi
4.06%
Cencora, Inc.
3.68%
AstraZeneca PLC
3.59%
Haleon Plc
3.23%
Teva Pharmaceutical Industries Ltd.
3.17%
GDOC
Eli Lilly & Co.
12.25%
Johnson & Johnson
8.25%
Merck & Co., Inc.
7.53%
UnitedHealth Group, Inc.
5.82%
Guardant Health, Inc.
4.22%
Vertex Pharmaceuticals, Inc.
4.12%
argenx SE
4.11%
DexCom, Inc.
3.69%
Thermo Fisher Scientific, Inc.
3.52%
Agilent Technologies, Inc.
3.47%
Edwards Lifesciences Corp.
3.40%
Intuitive Surgical, Inc.
2.82%
Lonza Group AG
2.80%
Cencora, Inc.
2.65%
Roivant Sciences Ltd.
2.57%
Frequently asked questions about PPH and GDOC

How have the PPH and GDOC ETFs performed in 2026?

As of October 23, 2026, PPH is up 13.41% year-to-date (YTD), while GDOC has returned 5.57%. That puts PPH better performer ahead so far this year.

Which ETF is attracting more investor money: PPH or GDOC?

Year-to-date, the PPH ETF saw -$316M in flows, compared to -$2M for GDOC.

Which ETF is more volatile: PPH or GDOC?

Over the past year, PPH had a volatility of 18.46%, while GDOC experienced 15.53%.

Which ETF is bigger: PPH or GDOC?

As of October 23, 2026, PPH holds $1.06 B in assets under management (AUM), while GDOC manages $19.75 M.

What sectors do the PPH and GDOC ETFs invest in?

PPH leans toward sectors like Healthcare. Meanwhile, GDOC focuses on Healthcare.

What are the top holdings of the PPH ETF and GDOC ETF?

PPH top holdings include Eli Lilly & Co., Merck & Co., Inc. and Novartis AG. GDOC holds in its top three: Eli Lilly & Co., Johnson & Johnson and Merck & Co., Inc..

Which ETF is more diversified: PPH or GDOC?

PPH holds 25 securities with 90.56% of its assets in the top 15. GDOC has 37 securities and a top 15 weight of 71.2%.

Advertisement
Latest news about PPH & GDOC
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026